lawsone has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Carvalho da Silva, F; de Freitas, PP; Dos Santos Guimarães, I; Ferreira, VF; Gimba, ERP; Moreira, CS; Ribeiro, RCB; Rocha, DR | 1 |
| Aissa, AF; Antunes, LMG; Batista, AA; De Grandis, RA; Machado, ART; Oliveira, KM; Pavan, FR; Santos, PWDSD | 1 |
2 other study(ies) available for lawsone and Cancer of Prostate
| Article | Year |
|---|---|
(3,3'-Methylene)bis-2-hydroxy-1,4-naphthoquinones induce cytotoxicity against DU145 and PC3 cancer cells by inhibiting cell viability and promoting cell cycle arrest.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; Male; Naphthoquinones; PC-3 Cells; Prostatic Neoplasms | 2021 |
Novel lawsone-containing ruthenium(II) complexes: Synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cattle; Cell Line, Tumor; Cell Movement; Coordination Complexes; DNA; Humans; Intercalating Agents; Male; Naphthoquinones; Prostatic Neoplasms; Reactive Oxygen Species; Ruthenium; Spheroids, Cellular | 2019 |